FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Constellation, Leukemia Society Partner on Hematologic Malignancies

[ Price : $8.95]

Constellation Pharmaceuticals and the Leukemia & Lymphoma Society enter into a partnership to develop a BET inhibitor for treating...

FDA OKs SPR Therapeutics Study for Post-Stroke Pain

[ Price : $8.95]

FDA approves a SPR Therapeutics Investigational Device Exemption to initiate a study of its SMARTPATCH Peripheral Nerve Stimulatio...

Bill to Authorize GDUFA Fee Collection

[ Price : $8.95]

Attorney Kurt Karst says Congress is likely to consider legislation to authorize FDA to collect some GDUFA fees without an appropr...

Doctors See Industry-funded Trials as Less Credible

[ Price : $8.95]

Researchers find that doctors think industry-funded research is less credible than trials funded by NIH.

OPDP Finds Multiple Problems in FazaClo Brochure

[ Price : $8.95]

CDERs Office of Prescription Drug Promotion warns Jazz Pharmaceuticals about a FazaClo patient brochure that it says suggests that...

Tighten Fraud Settlements: Professor

[ Price : $8.95]

Law school professor Kevin Outterson says Congress should consider ways to strengthen penalties imposed on companies and their exe...

ORA Headquarters Reorganizing

[ Price : $8.95]

ORA says its headquarters reorganization better positions it to work in the new global healthcare environment facing FDA.

Sanofi Collaborates to Develop New TB Treatments

[ Price : $8.95]

Sanofi and the Global Alliance for TB Drug Development sign a research collaboration agreement to discover and develop novel compo...

Guidance on Pentosan Polysulfate Sodium BE

[ Price : $8.95]

Federal Register Notice: FDA releases a draft guidance, Bioequivalence Recommendations for Pentosan Polysulfate Sodium.

Panel to Discuss Myeloma and Iron Overload Treatments

[ Price : $8.95]

Federal Register Notice: FDAs Oncologic Drugs Advisory Committee will meet 11/8 to discuss a Celgene NDA to treat mulitple myeloma...